![]() |
| |
8,10 $ | -17,35% | -1,70 $ |
01.02.13 | Trimedyne Reports Financial Results For The Quarter And Fiscal Year Ended September 30, 2012 | PR Newswire |
Branche | Pharmazie |
Herkunft | USA |
Website | www.trimedyne.com |
Aktienanzahl | 18,4 Mio. (Stand: 13.12.16) |
Marktkap. | 149,0 Mio. $ |
Keine Daten im genannten Zeitraum vorhanden |
Palatin Technologies, Inc. | 1,09 € | +0,93% | |
Albireo Pharma | 27,08 € | +3,91% | |
Cannabis Science | 0,05 € | +8,70% | |
Gilead Sciences | 60,05 € | -0,51% | |
Achieve Life Sciences | 1,08 € | +1,89% |